Skip to main content
Advertisement
  • Loading metrics

PLoS Medicine Issue Image | Vol. 19(1) January 2022

Accompanying the severe and widespread impacts of SARS-CoV-2 infection on hospitalizations and deaths in many countries around the world, evidence of chronic health sequelae has emerged. These manifestations can range from fatigue, shortness of breath, anxiety and depression to other serious instances of organ dysfunction, including pulmonary fibrosis and renal failure. In a Perspective, Kieran Quinn and Chaim Bell discuss an accompanying research study from Krishnan Bhaskaran and co-workers on people hospitalized with COVID-19 in England, as compared with the general population and those with influenza, and address the evolving area of health policy and planning related to the care of patients after hospitalization for COVID-19.

Image Credit: National Cancer Institute, Unsplash

thumbnail

Accompanying the severe and widespread impacts of SARS-CoV-2 infection on hospitalizations and deaths in many countries around the world, evidence of chronic health sequelae has emerged. These manifestations can range from fatigue, shortness of breath, anxiety and depression to other serious instances of organ dysfunction, including pulmonary fibrosis and renal failure. In a Perspective, Kieran Quinn and Chaim Bell discuss an accompanying research study from Krishnan Bhaskaran and co-workers on people hospitalized with COVID-19 in England, as compared with the general population and those with influenza, and address the evolving area of health policy and planning related to the care of patients after hospitalization for COVID-19.

Image Credit: National Cancer Institute, Unsplash

https://doi.org/10.1371/image.pmed.v19.i01.g001